HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Soumya Raychaudhuri Selected Research

Ulcer

11/2021IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Soumya Raychaudhuri Research Topics

Disease

41Rheumatoid Arthritis
11/2023 - 10/2008
10Autoimmune Diseases (Autoimmune Disease)
12/2023 - 05/2009
7Inflammation (Inflammations)
01/2024 - 01/2017
7Macular Degeneration (Age-Related Maculopathy)
01/2016 - 04/2010
6Arthritis (Polyarthritis)
02/2024 - 08/2009
6Neoplasms (Cancer)
12/2023 - 01/2003
5Lupus Nephritis
01/2024 - 01/2019
5Genetic Risk Score
06/2023 - 01/2011
5Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2022 - 01/2016
5Schizophrenia (Dementia Praecox)
10/2022 - 11/2014
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2018 - 01/2013
4Type 2 Diabetes Mellitus (MODY)
11/2022 - 01/2011
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2024 - 10/2018
3Communicable Diseases (Infectious Diseases)
12/2023 - 01/2021
3Juvenile Arthritis (Juvenile Idiopathic Arthritis)
11/2023 - 12/2015
3COVID-19
11/2022 - 08/2020
3Celiac Disease (Celiac Sprue)
11/2022 - 09/2014
3Hypersensitivity (Allergy)
10/2020 - 11/2014
3Crohn Disease (Crohn's Disease)
10/2019 - 01/2011
3Osteoarthritis
01/2019 - 01/2016
2Psoriasis (Pustulosis Palmaris et Plantaris)
10/2023 - 01/2022
2Infections
11/2022 - 05/2013
2Psoriatic Arthritis
01/2022 - 01/2016
2Ulcerative Colitis
01/2021 - 06/2011
2Disease Susceptibility (Diathesis)
01/2021 - 04/2015
2Genetic Predisposition to Disease (Genetic Predisposition)
01/2019 - 08/2016
2Rheumatic Diseases (Rheumatism)
01/2017 - 09/2015
2Insulin Resistance
09/2012 - 01/2012
1Proteinuria
01/2024
1Wounds and Injuries (Trauma)
01/2024
1Burkitt Lymphoma (Burkitt's Lymphoma)
01/2024
1Chronic Disease (Chronic Diseases)
03/2023
1Nephrotic Syndrome (Syndrome, Nephrotic)
01/2023
1Respiratory Insufficiency (Respiratory Failure)
11/2022
1IGA Glomerulonephritis (IGA Nephropathy)
11/2022
1Nephritis
01/2022
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Ulcer
11/2021
1Tuberculosis (Tuberculoses)
01/2021
1Drug Hypersensitivity (Drug Allergy)
10/2020

Drug/Important Bio-Agent (IBA)

14HLA Antigens (Human Leukocyte Antigens)IBA
01/2024 - 12/2012
14Proteins (Proteins, Gene)FDA Link
01/2020 - 09/2003
10Amino AcidsFDA Link
01/2022 - 01/2012
9HLA-DRB1 Chains (HLA DRB1)IBA
01/2022 - 01/2012
7Biomarkers (Surrogate Marker)IBA
01/2024 - 07/2015
7RNA (Ribonucleic Acid)IBA
11/2023 - 01/2019
5AntigensIBA
03/2023 - 01/2015
5CytokinesIBA
01/2022 - 08/2020
5HLA-B Antigens (HLA-B)IBA
10/2020 - 01/2012
4Tumor Necrosis Factor InhibitorsIBA
10/2023 - 04/2015
4Peptides (Polypeptides)IBA
11/2017 - 01/2012
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 07/2010
4AutoantibodiesIBA
04/2014 - 10/2008
3TNF Receptor-Associated Factor 1IBA
02/2024 - 02/2011
3Transcription Factors (Transcription Factor)IBA
01/2020 - 05/2013
3Complement Factor H (Factor H)IBA
01/2016 - 10/2011
3HLA-DPB1 antigen (HLA DPB1)IBA
01/2015 - 01/2012
2ChromatinIBA
12/2023 - 04/2023
2Membrane Proteins (Integral Membrane Proteins)IBA
11/2023 - 01/2021
2Antirheumatic Agents (DMARD)IBA
10/2023 - 01/2020
2Methotrexate (Mexate)FDA LinkGeneric
10/2023 - 01/2017
2InterferonsIBA
10/2018 - 03/2014
2histone H3 trimethyl Lys4IBA
10/2018 - 02/2013
2HLA-DQB1 antigen (HLA DQB1)IBA
10/2017 - 01/2012
2DNA (Deoxyribonucleic Acid)IBA
10/2015 - 03/2014
2di-n-hexyl sulfosuccinate (DHSS)IBA
07/2015 - 11/2014
2chemotactic factor inactivatorIBA
07/2015 - 11/2013
2AntibodiesIBA
03/2015 - 12/2012
2LDL Lipoproteins (beta Lipoproteins)IBA
06/2014 - 02/2013
2LipidsIBA
09/2012 - 01/2011
2Anti-Citrullinated Protein AntibodiesIBA
01/2011 - 08/2009
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2024
1Interferon Type IIBA
01/2024
1LuciferasesIBA
11/2023
1Abatacept (Orencia)FDA Link
10/2023
1Ustekinumab (CNTO 1275)FDA Link
10/2023
1Antigen Receptors (Antigen Receptor)IBA
03/2023
1Insulin ReceptorIBA
01/2023
1Immunologic Factors (Immunomodulators)IBA
01/2023
1Immunoglobulin A (IgA)IBA
11/2022
1Triglycerides (Triacylglycerol)IBA
10/2022
1Eosine Yellowish-(YS) (Eosin)IBA
04/2022
1Hematoxylin (Haematoxylon)IBA
04/2022
1adavosertibIBA
01/2022
1Interleukin-16 (Interleukin 16)IBA
01/2022
1EpitopesIBA
01/2022
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022
1Chemotactic FactorsIBA
11/2021
1Adenosine Monophosphate (AMP)IBA
01/2021
1chenodeoxycholate sulfate conjugate (CDCS)IBA
01/2021
1Bacterial ToxinsIBA
01/2021
1Penicillins (Penicillin)FDA Link
10/2020
1Interleukin-6 (Interleukin 6)IBA
10/2020
1Interleukin-17 (Interleukin 17)IBA
10/2020

Therapy/Procedure

10Therapeutics
01/2024 - 07/2010
2Transplantation
12/2023 - 03/2023
2Immunotherapy
01/2021 - 01/2016
2Immunomodulation
01/2021 - 08/2020
2Biological Therapy
01/2017 - 03/2013
1Precision Medicine
01/2023